STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Signal transducer and activator of transcription 3 (STAT3) is a key regulator of cell survival and growth, often dysregulated in cancer.
• STAT3 has demonstrated anti-apoptotic effects in breast cancer cells, contributing to tumor progression.
• MicroRNAs (miRNAs) play crucial roles in gene expression and are implicated in various cancers, including breast cancer.

Purpose of the Study:

• To investigate the role of miR-17-5p in regulating apoptosis in breast cancer cells.
• To elucidate the molecular mechanism by which miR-17-5p influences apoptosis, particularly in relation to STAT3 and p53.
• To determine if miR-17-5p can sensitize breast cancer cells to chemotherapy.

Main Methods:

• Cell culture of human breast cancer cell line (MCF-7).
• Overexpression and knockout of STAT3 and miR-17-5p.
• Assessment of apoptosis using standard assays.
• Western blotting to analyze protein expression levels of STAT3 and p53.
• Treatment with paclitaxel to evaluate chemosensitization.

Main Results:

• Overexpression of miR-17-5p induced apoptosis in breast cancer cells.
• miR-17-5p sensitized MCF-7 cells to paclitaxel-induced apoptosis, an effect mediated by STAT3.
• Overexpression of STAT3 reduced paclitaxel-induced apoptosis, while STAT3 knockout abolished the pro-apoptotic effect of miR-17-5p.
• miR-17-5p promoted apoptosis by upregulating p53 expression, an effect that was suppressed by STAT3.

Conclusions:

• miR-17-5p exerts anti-cancer effects in breast cancer by inducing apoptosis.
• A novel pathway is identified where miR-17-5p inhibits STAT3 and enhances p53 expression, leading to increased apoptosis.
• This pathway represents a potential therapeutic target for breast cancer treatment, particularly in overcoming chemoresistance.